D
BioMarin Pharmaceutical Inc. BMRN
$58.58 $0.510.88% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 18.36% 19.36% 17.97% 19.14% 15.83%
Total Other Revenue -- -- -- -- --
Total Revenue 18.36% 19.36% 17.97% 19.14% 15.83%
Cost of Revenue 3.94% 4.98% 9.96% -6.96% -23.46%
Gross Profit 26.18% 27.66% 22.56% 40.63% 60.56%
SG&A Expenses -10.53% -1.53% 2.33% 17.10% 12.55%
Depreciation & Amortization -59.08% -44.43% -30.47% -22.02% -5.35%
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -6.00% -1.54% 2.26% 12.07% 10.56%
Operating Income 239.64% 254.49% 206.85% 115.80% 104.47%
Income Before Tax 181.25% 184.09% 187.31% 158.08% 176.29%
Income Tax Expenses 334.30% 371.57% 449.31% 1,385.08% 418.73%
Earnings from Continuing Operations 156.15% 154.99% 154.62% 119.21% 156.61%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 156.15% 154.99% 154.62% 119.21% 156.61%
EBIT 239.64% 254.49% 206.85% 115.80% 104.47%
EBITDA 163.07% 162.62% 129.69% 69.35% 60.12%
EPS Basic 153.60% 152.09% 151.39% 116.68% 154.11%
Normalized Basic EPS 221.12% 234.78% 207.56% 100.43% 96.60%
EPS Diluted 158.99% 157.25% 157.15% 117.91% 156.99%
Normalized Diluted EPS 226.33% 236.07% 205.17% 97.92% 94.99%
Average Basic Shares Outstanding 1.10% 1.15% 1.17% 1.21% 1.26%
Average Diluted Shares Outstanding 0.58% 1.73% 2.73% 2.89% 2.86%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --